Keith A. Goldan

Insider Reports History

Location
Conshohocken, PA
Signature
/s/ Joseph Vazzano, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith A. Goldan:

Form 4 holding Chief Financial Officer

Syndax Pharmaceuticals Inc

Security class
Stock Options (Right to buy)
Shares / value
118,000
Estimated value
$2,410,740
Report date
04 Feb 2026
Price
$20.43
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

OptiNose, Inc.

Security class
Common Stock
Shares / value
141,726
Estimated value
$162,985
Report date
16 Mar 2022
Price
$1.15
Ownership
Direct

Insider Reports Filed by Keith A. Goldan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .